Fajardo AF, Gowda CP, Johnson E, Petroni R, et al. In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis. Oncogene 2026 Jun 17. doi: 10.1038/s41388-026-03851.
PMID: 42310097